What’s a potential medical breakthrough without a little controversy? Resia Pretorius Ph.D., a South African researcher from the Stellenbosch University in South Africa, and her colleague Douglas Kell from the University of Liverpool, UK, are right in the thick...
“B. miyamotoi is a prime candidate to be the major chronic infection underlying ME/CFS” The fifth in a series of blogs reporting on the 2022 IACFS/ME Conference focuses on an intriguing possibility: that heretofore unknown infection is present in most...
Suzanne Vernon’s interest in pathogens and post-infectious diseases goes back to when, as a 20-year-old, she landed a work-study job at the CDC’s Division of Vector-Borne Diseases while an undergraduate at Colorado State University. Ten years later with...
It’s nice to have a billionaire in your corner. Earlier this year, billionaire Vitalik Buterin pledged to devote $100 million to high-risk, high-reward COVID-19 efforts. He made good on at least $15 million of that when he jumpstarted The Long COVID...
This is the second in a series of blogs on the IACFS/ME 2022 International Conference on ME/CFS (and long COVID). The last one focused on David Systrom’s Keynote address. This one focused on an hour-long talk that kicked off the keynote session. Systrom’s...
The BA.5 Omicron Subvariant: The Worst Coronavirus Yet? Variants of Concern Many variants of the SARS-CoV-2 coronavirus have been found, but since the Delta variant showed up in Oct 2020, only six have been considered “variants of concern”. Today, only...
